ELECTIVE CAESAREAN SECTION AND MODALITIES OF ANTIBIOPROPHYLAXIS
Abstract
Caesarean section (CS) is an often necessary operation widely used in obstetrics. After CS, infectious morbidity is the most common complication. The study aimed to compare the effectiveness of a single dose of ceftriaxone intraoperatively (2.0 g) with a three-day regimen of ceftriaxone postoperatively (2.0 g/24 h) in the prevention of postoperative complications in patients undergoing elective CS. This research included 68 patients for an elective CS. Patients were divided into two groups of 34 subjects randomly assigned to receive ceftriaxone in the form of a single dose (2.0 g) intraoperatively, or three-day ceftriaxone (2.0 g/24 h) postoperatively. А CS was performed using standard technique. Postpartum complications were recorded. An examination, microbiological diagnosis, and adequate dressing of the wounds were performed. At discharge, patients were instructed to report any irregularities. The results were statistically processed. Postpartum complications occurred in 7 patients in the first group, 5 patients had fever and 2 did not have fever. Of the 5 febrile patients, 3 had wound infection, 1 endometritis, and 1 transient postpartum febrility. In the second group, 9 patients had complications, 6 patients had fever, and 3 had no fever. Of the 6 patients with fever, 3 had wound infection, 1 had endometritis, 1 had urinary infection, and 1 transient postpartum febrility. There was no reduction in the incidence of postoperative morbidity in patients who received ceftriaxone in a three-day regimen. Results showed that the three-day use of antibiotics was unjustified because it did not reduce the risk of postoperative morbidity. The prophylactic administration of antibiotics in elective CS is the most adequate modality of antibiotic administration. Research indicates the benefit of intraoperative monodose administration after umbilical cord clamping.
References
Bagratee JS, Modley J, Kleinschmidt I, Zawilski W. A randomised controlled trial of antibiotic prophylaxis in clective caesarcan delivery. BJOG 2001;108(2):143-8. [CrossRef] [PubMed]
Bollig C, Nothacker M, Lehane C, Motschall E, Lang B, Meerpohl J, et al. Prophylactic antibiotics before cord clamping in cesarean delivery: a systematic review. Acta Obstet Gynecol Scand 2018;97(5):521-35. [CrossRef] [PubMed]
Bratzler DW, Dellinger EP, Olsen KM, Trish MP, Auwaerter GP, Bolon KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013;70(3):195-283. [CrossRef] [PubMed]
Dinsmoor MJ, Gilbet S, Landon MB, Rouse JD, Spong YC, Varner WM et al. Perioperative antibiotic prophylaxis for nonlaboring cesarean delivery. Obstet Gynecol 2009;114(4):752-6. [CrossRef] [PubMed]
Henderson E, Love EJ. Incidence of hospital- acquired associated with caesarcan section. J Hosp Infect 1995; 29(49:245-55. [CrossRef] [PubMed]
Killian CA, Graffinder EM, Vinciguera TI, Venecia RA. Risk factors for surgical-site infections folowing caesarean section. Infect Control Hosp Epidemiol 2001; 22(10):613-7. [CrossRef] [PubMed]
Mah MW, Pyper AM, Oni GA, Memish ZA. Impact of antibiotic prophylaxis on wound infection after caesarean section in a situation of expected higher risk. Am J Infect Control 2001;29(2):85-8. [CrossRef] [PubMed]
Mandach U. A randomised controlled trial of antibiotic prophylaxis in elective caesarcan delivery. BJOG 2002;109(12):1423-4. [CrossRef] [PubMed]
Meyer NL, Hosier KV, Scott K, Lipscomb GH. Cefazolin versus Cefazolin plus Metronidazole prophylaxis at Cacsarcan Section. South Med J 2003;96(10):992-995 [CrossRef] [PubMed]
Normand MC, Damato EC. Postcesarean infection. J Obstet Gynecol Neonatal Nurs 2001;30(6):642-8. [CrossRef] [PubMed]
Raghunathan K, Connelly NR, Friderici J, Naglieri-Prescorod D, Joyse R, Prasanna P, et al. Unwarranted variability in antibiotic prophylaxis for cesarean section delivery: a national survey of anesthesiologists. Anesth Analg 2013;116(3):644-8. [CrossRef] [PubMed]
Schein M. Caesarcan section. A manual for doctors. World J Surg 2006;30:655-7. [CrossRef]
Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev 2014;(10):CD007482. [CrossRef] [PubMed]
Swartz WH, Cirolle K. The use of prophylactic antibiotics in caesarcan section. A review of the literature. J Reproductive Med 1999; 26(12):595-609. [PubMed]
Yip SK., Lau TR., Rogers MS. A study on prophylactic antibiotics in caesarean section- is it worthwhile? Acta Obstet Gynecol
